Medical News

Empirical Antibiotics for Acute Cholecystitis – What Generat...
J Hepatobiliary Pancreat Sci.

The empirical use of first‐generation cephalosporins for mild‐to‐moderate AC without gallbladder perforation was...

01 Mar 2021

Shorter and Longer Courses of Antibiotics for Common Infecti...
Clin Infect Dis.

Equal effectiveness was found between shorter and longer antibiotic courses and the reduction of infection-related...

26 Feb 2021

Etiological and Predictive Factors of Pediatric Urticaria In...
‎BMC Pediatr.

The present study has found that infection was the most common cause of acute urticaria in children.

23 Feb 2021

Outcomes of Inhaled Amikacin-Containing Multidrug Regimens f...
Chest.

Inhaled amikacin with or without clofazimine in the regimen provides favorable treatment outcomes in M. massiliense...

22 Feb 2021

Key Trials

IV Colistin vs. Combination of IV plus Inhaled Colistin in Critically Ill Children with MDR GNB-associated VAP

Amongst critically ill pediatric patients with MDR GNB-associated VAP, treatment with inhaled plus IV colistin yielded clinical and microbiological...

Pharmacokinetics of Meropenem by Continuous Infusion in Critically Ill Patients with Nosocomial Pneumonia

Administration of meropenem by continuous infusion improves drug exposure in plasma and epithelial lining fluid (ELF) in critically ill patients...

Colistin & β-lactams – No Significant Difference in Nephrotoxicity Study

This study highlights that colistin is erroneously blamed for nephrotoxicity and nephrotoxicity rates may be over-estimated as AKI is common in...

Simple Intervention Bundle Improves Antimicrobial Stewardship Practices

A simple, low-cost quality intervention bundle can significantly increase appropriate antimicrobial prescribing and appropriate investigations and...

Slide Library

Cefuroxime (Novacef)

Cefuroxime is a second-generation cephalosporin antibiotic. It is a broad-spectrum antibacterial agent with a favorable pharmacokinetic profile....

 
Email this page
Management of Mucormycosis in ENT Practice

Mucormycosis are the group of invasive infection caused by filamentous fungi of the Mucoraceae family. This slide set enumerates prevalence,...

 
Email this page
Antifungal Therapy in Immunocompromised Patients

Early initiation of antifungal therapy is a major contributor to enhanced survival rate. This set of slides highlights incidence and risk factors of...

 
Email this page
Disseminated Tuberculosis with ARDS

Disseminated TB results from widespread blood borne dissemination of TB bacilli. This presentation includes causes and risk factors of disseminated...

 
Email this page

Our Publications

Cytorx (Flucytosine) Monograph

This monograph describes the role of Flucytosine tablets in the management of invasive cryptococcal infections and some Candida spp. infections.  

Clarithromycin: An Emerging Treatment Recourse in Lower Respiratory Tract Infections

Parenteral macrolide therapy is needed for patients with moderate to severe CAP/AECB. This booklet gives an overview of the efficacy and safety of...

MRSA: The Clinician’s Challenge

The article summarizes the Indian epidemiological data for MRSA infections, along with treatment of MRSA infections and infection control measures.

Phosome IV (Liposomal Amphotericin B) Monograph

Amphotericin B deoxycholate has a broad antifungal activity, and today it is the best antifungal available against most systemic fungal infections,...

Poll

Do you perceive any clinical benefits of neurotrophic agent in the management of acute brain injury?
Yes
25% (2 votes)
Sometimes
25% (2 votes)
No
50% (4 votes)
Total votes: 8